Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThis updates the displayed software/site revision from v3.5.2 to v3.5.3 on the ClinicalTrials.gov record history page.SummaryDifference0.0%

- Check23 days agoChange DetectedA new revision entry v3.5.2 was added, and the previous revision v3.5.0 was removed from the page history.SummaryDifference0.0%

- Check52 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check59 days agoChange DetectedFooter now displays Revision: v3.4.3, replacing Revision: v3.4.2 as part of a site update. This change does not affect study data or content on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedRecruitment status updated from Recruiting to Active, not recruiting; the update adds Study Status and Contacts/Locations sections on 2026-02-27.SummaryDifference0.3%

- Check88 days agoChange DetectedA new Revision: v3.4.2 was added to the History, while the funding-status notice and Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.